XORTX Therapeutics Inc Financial Overview
XORTX Therapeutics Inc's market cap is currently C$3.57M. The company's EPS TTM is $-0.13; its P/E ratio is -1.16; XORTX Therapeutics Inc is scheduled to report earnings on November 15, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
